For: | Liu H, Zhang QD, Li ZH, Zhang QQ, Lu LG. Efficacy and safety of gemcitabine-based chemotherapies in biliary tract cancer: A meta-analysis. World J Gastroenterol 2014; 20(47): 18001-18012 [PMID: 25548500 DOI: 10.3748/wjg.v20.i47.18001] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i47/18001.htm |
Number | Citing Articles |
1 |
Subhajit Ghosh, Tapas Das, Haladhar D. Sarma, Ashutosh Dash. The potential of radiolabeled chemotherapeutics in tumor diagnosis: Preliminary investigations with 68Ga‐gemcitabine. Drug Development Research 2018; 79(3): 111 doi: 10.1002/ddr.21423
|
2 |
Jason Ho, Steven A. Curley. Gastrointestinal Malignancies. Cancer Treatment and Research 2016; : 121 doi: 10.1007/978-3-319-34244-3_7
|
3 |
Omar Abdel-Rahman, Zeinab Elsayed, Hesham Elhalawani. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. Cochrane Database of Systematic Reviews 2018; 2018(4) doi: 10.1002/14651858.CD011746.pub2
|
4 |
Aileen Deng, Steven Cohen. Primary and Metastatic Liver Tumors. 2018; : 137 doi: 10.1007/978-3-319-91977-5_11
|
5 |
Yaoqun Wang, Ningyuan Wen, Shaofeng Wang, Guilin Nie, Yuan Tian, Jiong Lu, Bei Li. Chemotherapy and targeted therapy for advanced biliary tract cancers: an umbrella review. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10679-8
|
6 |
Wei Li, Xiujun Song, Huijie Yu, Manze Zhang, Fengsheng Li, Cheng Cao, Qisheng Jiang. Dendritic cell-based cancer immunotherapy for pancreatic cancer. Arab Journal of Gastroenterology 2018; 19(1): 1 doi: 10.1016/j.ajg.2017.05.013
|
7 |
Lars Henrik Jensen. Clinical aspects and perspectives of erlotinib in the treatment of patients with biliary tract cancer. Expert Opinion on Investigational Drugs 2016; 25(3): 359 doi: 10.1517/13543784.2016.1142973
|
8 |
Wen-Kuan Huang, Chun-Nan Yeh. The Emerging Role of MicroRNAs in Regulating the Drug Response of Cholangiocarcinoma. Biomolecules 2020; 10(10): 1396 doi: 10.3390/biom10101396
|
9 |
Cheng Zhang, Ke Li, Shu-Ning Xu, Lei Qiao, Yu-Lin Ren, Qun Li, Ying Liu. A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) for gemcitabine. Expert Opinion on Drug Safety 2024; : 1 doi: 10.1080/14740338.2024.2419999
|
10 |
Anand Singla, Richard A. Kozarek. Advanced Therapeutic Endoscopy for Pancreatico-Biliary Diseases. 2019; : 285 doi: 10.1007/978-4-431-56009-8_26
|